Viewing Study NCT01931566


Ignite Creation Date: 2025-12-24 @ 4:09 PM
Ignite Modification Date: 2026-01-20 @ 5:26 PM
Study NCT ID: NCT01931566
Status: TERMINATED
Last Update Posted: 2019-09-16
First Post: 2013-08-26
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset
Sponsor: Takeda
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mild Cognitive Impairment Due to Alzheimer's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Drug therapy View